Table 1 The clinical characteristics of the two groups
Variables | IVC (n = 57) | IVC + RA (n = 18) | p |
|---|---|---|---|
Age (years) | 54.6 ± 10.6 | 51.9 ± 10.3 | 0.340 |
Gender | |||
 Male | 50 (87.7%) | 16 (88.9%) | 0.631 |
 Female | 7 (12.3%) | 2 (11.1%) | |
Performance status | |||
 0 | 14 (24.6%) | 3 (16.7%) | 0.543 |
 1 | 43 (75.4%) | 15 (83.3%) |  |
Child-Pugh classification | |||
 A | 51 (89.5%) | 15 (83.3%) | 0.678 |
 B | 6 (10.5%) | 3 (16.7%) |  |
Intrahepatic tumor number | |||
 Solitary | 43 (75.4%) | 11 (61.1%) | 0.238 |
 Multiple | 14 (24.6%) | 7 (38.9%) |  |
LN metastases | |||
 Absent | 53 (93.0%) | 15 (83.3%) | 0.348 |
 Present | 4 (7.0%) | 3 (16.7%) |  |
Distant metastases | |||
 Absent | 44 (77.2%) | 10 (55.6%) | 0.075 |
 Present | 13 (22.8%) | 8 (44.4%) |  |
HBsAg | |||
 Negative | 5 (8.8%) | 1 (5.6%) | 0.555 |
 Positive | 52 (91.2%) | 17 (94.4%) |  |
AFP (μg/L) | |||
  < 400 | 31 (54.4%) | 13 (72.2%) | 0.180 |
  ≥ 400 | 26 (45.6%) | 5 (27.8%) |  |
No. of prior therapies | 3.7 ± 1.5 | 4.1 ± 1.7 | 0.407 |